QualityStocksNewsBreaks Archives - Page 368 of 1465

FridayJan 06, 2023 11:13 am

QualityStocksNewsBreaks – Cepton Inc.’s (NASDAQ: CPTN) Vista-X120 Plus Featured in FreightWaves Article

Cepton (NASDAQ: CPTN), a Silicon Valley innovator of high-performance lidar solutions, was featured in a recent article published by FreightWaves. The piece, written by Jack Daleo and titled “Cepton unveils slimmed-down lidar solution,” discusses the Vista-X120 Plus, which offers easy integration at a height of 30 mm. “As the autonomous vehicle industry begins to gather steam, manufacturers of lidar — short for light detection and ranging — are trying to do more with less. Cepton (NASDAQ: CPTN), one of the few publicly traded lidar companies in the U.S., on Tuesday unveiled the Vista-X120 Plus, billed as ‘the world’s slimmest software…

FridayJan 06, 2023 10:16 am

QualityStocksNewsBreaks – Reklaim Ltd. (TSX.V: MYID) (OTCQB: MYIDF), Snowflake Partner to Help Fill Gap in US Data Market

Reklaim (TSX.V: MYID) (OTCQB: MYIDF), a leader in privacy-compliant data, today announced its collaboration with Snowflake, the Data Cloud company, to offer two compliant data sets on Snowflake Marketplace. These include a data set of individual consumers who have explicitly opted-in to sharing their sensitive personal data (“SPI”) for marketing purposes, as well as a do-not-sell data set of consumers who have specifically opted out of having their data sold. “With the enforcement period of CCPA beginning in January of 2023, offering distinct consumer consent for SPI data and do-not-sell signals to companies looking to ensure their data remains compliant…

FridayJan 06, 2023 10:09 am

QualityStocksNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Releases Study Results Indicating Inhaled COVID-19 Therapy Virtually Eliminated SARS-COV-2 Virus

BiondVax Pharmaceuticals (NASDAQ: BVXV), a biotech company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, is reporting additional results from a preclinical in vivo proof-of-concept study. The study evaluated BVXV’s innovative inhaled nanosized antibody (“NanoAb”) COVID-19 therapy; results indicate that the presence of the SARS-COV-2 virus in the lungs of hamsters treated with BiondVax’s NanoAb was “virtually eliminated” and significantly less than the amount of virus detected in the placebo group. Specifically, hamsters infected with SARS-COV-2 that were treated with BiondVax’s inhaled anti-COVID-19 nanosized antibodies had more than 30 times…

FridayJan 06, 2023 9:49 am

QualityStocksNewsBreaks – SideChannel Inc. (SDCH) CEO Weighs In on Cybersecurity Protection

SideChannel (OTCQB: SDCH) CEO Brian Haugli is one of several cybersecurity experts quoted in a recent “Information Week” article outlining five questions to ask about protecting a business. The article mentioned a widespread phishing campaign that took place last August against customer-engagement platform Twilio and content-delivery network Cloudflare. The cyberattack stole nearly 10,000 sets of credentials, with the tally rising much higher if downstream customers that were impacted were included in the count. Haugli addressed the fact that even if a company “has a firm grasp of IAM within their own four walls, risk extends much further. The Twilio supply chain…

ThursdayJan 05, 2023 1:15 pm

QualityStocksNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Secures Stream of Steady Business on Fr8App Platform

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”), a company specializing in creating and providing supply chain optimization and automation solutions, and Freight App Inc. (“Fr8App”), its wholly owned subsidiary, have always sought to create offerings that contribute to their clients’ success by improving efficiency and profitability. “Designed to help solve shippers’ needs to secure freight capacity over time rather than on a trip-by-trip basis and guarantee carriers a steady stream of revenue, Fr8PrivateFleet matches carriers with the capacity for predetermined amount of load over a stated period with shippers… The advantages of Fr8PrivateFleet persuaded new and existing Fr8App customers to integrate it…

ThursdayJan 05, 2023 1:13 pm

QualityStocksNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Receives Key Patent from European Patent Office

HeartBeam (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector electrocardiogram (“VECG”) platform for heart attack detection anytime, anywhere, has been issued a patent by the European Patent Office. The company received notification that the patent was issued covering the company’s flagship technology that enables generation of a synthesized 12-lead ECG by the HeartBeam AIMIGo(TM) credit card-sized device. This patent offers protection in multiple countries in Europe and has been validated in France, Germany, Netherlands and the United Kingdom. The company noted that the newly issued patent “expands on HeartBeam’s granted and pending core patents…

ThursdayJan 05, 2023 12:31 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO to Present at Virtual Investor 2023 ‘Companies to Watch’

CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system. The company today announced that its Chief Executive Officer John Climaco will present at the Virtual Investor 2023 “Companies to Watch” event. Climaco’s presentation is scheduled to take place beginning at 10 a.m. ET on Wednesday, Jan. 18, 2023. A live video webcast of the presentation will be available on the Events page of CNS Pharmaceuticals’ website, and a replay will be available two hours following the live presentation and accessible for 90…

ThursdayJan 05, 2023 12:25 pm

QualityStocksNewsBreaks – MetAlert Inc. (MLRT) Issues Shareholder Update

MetAlert (OTC: MLRT), a pioneer in location-sensitive health monitoring devices and wearable technology products for remote patient monitoring, today issued its year-end shareholder letter. In the update, the company’s CEO and Founder Patrick Bertagna shared insight on the company’s restructuring, branding and efforts to attract new investors and larger customers to execute its growth strategy, as well as the milestones that will shape MetAlert’s future. “We are now taking dramatic steps to align the public-facing (stock) part of the company with the operations and vision of the company. Although the short-term performance of the stock has not been what we…

ThursdayJan 05, 2023 11:20 am

QualityStocksNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Releases Status Update on Commercial Cannabis Export Business

Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, is reporting on its commercial cannabis operations out of Colombia. According to the status update, the company exported an estimated 1,000 kilograms of commercial cannabis dry flower and derivatives to Europe and the United States in the fourth quarter of 2022; the company also received an updated cannabis export and production quota from the Colombian government, which included the addition of four additional proprietary genetics and increased production for domestic medical markets. The company noted that this activity is a result of the full…

ThursdayJan 05, 2023 10:55 am

QualityStocksNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Announces Participation in Upcoming Biotech Showcase

BiondVax Pharmaceuticals (NASDAQ: BVXV) CEO Amir Reichman will be presenting at the Biotech Showcase Conference, scheduled for Jan. 9–11, 2023. The conference is being held in San Francisco during the J.P. Morgan 41st annual Healthcare Conference. BiondVax board chair Mark Germain will also be available throughout the conference to meet with potential partners, collaborators and investors. BiondVax is a biotech company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases. Reichman’s presentation, which will focus on recent successful preclinical in vivo trial results of BiondVax’s inhaled COVID-19 therapy, is slated for…

Site Search

Company Search

Category: QualityStocksNewsBreaks